TRCT
NXTC icon

Tower Research Capital (TRC)’s NextCure NXTC Stock Holding History

Tower Research Capital (TRC)’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-127
Closed -$703 – 5490
2025
Q2 		$703 Sell
127
-29
-19% -$156 ﹤0.01% 4958
2025
Q1 		$898 Buy
156
+101
+184% +$891 ﹤0.01% 4808
2024
Q4 		$508 Buy
+55
New +$809 ﹤0.01% 5250
2024
Q3 		– Sell
-102
Closed -$1.95K – 5906
2024
Q2 		$1.95K Sell
102
-88
-46% -$1.71K ﹤0.01% 5072
2024
Q1 		$5.07K Sell
190
-484
-72% -$8.34K ﹤0.01% 4588
2023
Q4 		$9.22K Buy
674
+87
+15% +$1.26K ﹤0.01% 4422
2023
Q3 		$9.09K Buy
587
+282
+92% +$5.38K ﹤0.01% 4268
2023
Q2 		$6.58K Sell
305
-870
-74% -$17.1K ﹤0.01% 4682
2023
Q1 		$21K Sell
1,175
-586
-33% -$11.3K ﹤0.01% 3390
2022
Q4 		$30K Buy
1,761
+396
+29% +$9.11K ﹤0.01% 2748
2022
Q3 		$45K Buy
1,365
+684
+100% +$34.9K ﹤0.01% 3260
2022
Q2 		$38K Sell
681
-858
-56% -$44.8K ﹤0.01% 3145
2022
Q1 		$90K Buy
1,539
+1,256
+444% +$78.6K ﹤0.01% 2291
2021
Q4 		$20K Sell
283
-94
-25% -$7.86K ﹤0.01% 3675
2021
Q3 		$31K Buy
377
+162
+75% +$14.2K ﹤0.01% 3357
2021
Q2 		$21K Buy
215
+41
+24% +$4.2K ﹤0.01% 3850
2021
Q1 		$21K Sell
174
-320
-65% -$46.3K ﹤0.01% 3844
2020
Q4 		$65K Sell
494
-920
-65% -$119K ﹤0.01% 2821
2020
Q3 		$149K Buy
1,414
+1,219
+625% +$150K ﹤0.01% 2822
2020
Q2 		$50K Buy
195
+166
+572% +$63.2K ﹤0.01% 3047
2020
Q1 		$13K Buy
29
+21
+263% +$11.2K ﹤0.01% 1912
2019
Q4 		$6K Sell
8
-24
-75% -$12K ﹤0.01% 2603
2019
Q3 		$12K Sell
32
-499
-94% -$162K ﹤0.01% 2831
2019
Q2 		$96K Buy
+531
New +$110K 0.01% 1197

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC)'s NXTC Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of NextCure (NXTC) in Q3 2025, closing a stake of 127 shares — an estimated $703 sold.

Tower Research Capital (TRC) first reported a position in NXTC in Q2 2019 and held it in 24 quarters. The position peaked at $149K in Q3 2020. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 127 NextCure shares in Q3 2025, an estimated $703.
  • Tower Research Capital (TRC) first reported a position in NextCure in Q2 2019 and held it in 24 quarters.
  • Tower Research Capital (TRC)'s NextCure position peaked at $149K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.